Year: 2026
Type: editorial
Abstract: While methodological innovation is essential, experimental validation remains equally important. In lung adenocarcinoma, Judong Luo and colleagues integrated scRNA-seq, spatial transcriptomics, and immunofluorescence analyses to characterize changes in cell-cell communication during histological progression from lepidic to solid tumor patterns. Their study revealed that immune-suppressive communication networks progressively intensify during tumor evolution. In particular, the TIGIT-NECTIN2, PVR-TIGIT, and PD-1/PD-L1 axes emerged as critical pathways associated with immune evasion, macrophage recruitment, and T-cell exhaustion. By combining computational inference with spatial validation, the authors demonstrated the co-localization of receptor-ligand pairs within tumor tissues and linked these interactions to clinical outcomes and therapeutic responsiveness. The study underscores how multimodal validation can transform communication predictions into biologically and clinically meaningful mechanisms.A complementary example of translational application is provided by Cong Fu and colleagues in clear cell renal cell carcinoma (ccRCC). Integrating scRNA-seq and spatial transcriptomics, the authors identified epithelial-cell-associated prognostic signatures and generated a robust risk stratification model based on seven genes. Beyond prognostic modeling, the study uncovered ATP1A1 as a potential mediator linking vascular biology and immune regulation. Functional validation demonstrated that ATP1A1 inhibited endothelial cell migration and angiogenesis while promoting M1 macrophage polarization. These findings illustrate how integrating communicationaware spatial analyses with functional studies can reveal biomarkers and therapeutic targets that connect cellular interactions to disease outcomes. More broadly, the work highlights how CCC research is increasingly moving from descriptive network reconstruction toward clinically actionable discoveries.Extending the scope of the Topic beyond oncology, Sílvia Sisó and colleagues applied a comprehensive spatial multi-omics framework to rheumatoid arthritis (RA), integrating multiple spatial transcriptomic platforms, spatial proteomics, multiplex immunohistochemistry, and computational pathology. Their study represents an important contribution to the understanding of tissue architecture in chronic inflammatory disease. Cross-platform analyses demonstrated substantial concordance in cellular composition and localization while highlighting the complementary strengths of different spatial technologies. Most notably, the authors identified a previously unrecognized laminar organization of fibroblast subtypes within the RA synovium. Through single-cell spatial analyses, they revealed distinct fibroblast populations occupying lymphoid, vascular, and stromal niches and demonstrated how these subtypes form diseaseassociated cellular neighborhoods. By linking spatial organization to pathway activities and tissue microenvironments, the study illustrates how advanced spatial multi-omics approaches can uncover layers of cellular communication and organization that are inaccessible to dissociationbased methods.Taken together, these four studies illustrate several important trends shaping the future of cellcell communication research. First, the field is increasingly moving beyond cataloging ligandreceptor interactions toward understanding cellular interactions within their spatial and physical contexts. Physical proximity, tissue architecture, and cellular neighborhoods are emerging as critical determinants of communication fidelity. Second, multimodal integration is becoming an important frontier. The combination of scRNA-seq, spatial transcriptomics, proteomics, imaging technologies, and computational modeling provides a more comprehensive and reliable view of cellular interactions than any single modality alone. Third, validation is receiving greater emphasis. Studies in this Topic consistently demonstrate the value of combining computational predictions with spatial, histological, or functional evidence. Finally, CCC research is becoming increasingly translational, with discoveries being linked to prognosis, therapeutic response, immune regulation, and disease mechanisms.Despite remarkable progress, significant challenges remain. First, current spatial transcriptomics technologies vary substantially in spatial resolution, gene coverage, and measurement sensitivity, creating challenges for cross-platform analyses and method generalization. This field would benefit from unified, robust, and scalable frameworks capable of systematically inferring spatially resolved CCC at single-cell resolution across divers platforms. Second, comparative and longitudinal analyses of CCC across biological states, developmental stages, disease progression, and treatment responses remain underexplored. Such analyses can reveal how communication networks are dynamically rewired over time and across contexts. Furthermore, translating inferred interactions into functional and causal mechanisms remains an important frontier. Emerging technologies such as spatially-resolved CRISPR screens may enable direct testing of the causal effects of specific L-R interactions.The studies collected in this Research Topic exemplify the maturation of the CCC field from computational inference toward mechanistic understanding. By sharpening both computational and experimental tools, CCC research will move beyond descriptive analysis toward predictive and intervention-oriented modeling, enabling the prediction of how intercellular communication responds to genetic, pharmacological, or environmental perturbations in cancer, autoimmune disease, and beyond. As technologies continue to evolve, such integrative approaches will be instrumental in translating cellular interaction maps into biological understanding and ultimately into improved diagnostic and therapeutic strategies.
Source: Frontiers in Immunology
Authors: Qingfei Pan, Koon-Kiu Yan, Suoqin Jin
Institutions: St. Jude Children's Research Hospital, Wuhan University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7223047015